0001599298-24-000060.txt : 20240404
0001599298-24-000060.hdr.sgml : 20240404
20240404175223
ACCESSION NUMBER: 0001599298-24-000060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soni Manmeet Singh
CENTRAL INDEX KEY: 0001569769
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 24824229
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-460-8308
MAIL ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wk-form4_1712267527.xml
FORM 4
X0508
4
2024-04-02
0
0001599298
Summit Therapeutics Inc.
SMMT
0001569769
Soni Manmeet Singh
C/O SUMMIT THERAPEUTICS INC.
601 BRICKELL KEY DRIVE, SUITE 1000
MIAMI
FL
33131
1
1
0
0
Chief Operating Officer
0
Stock Option (right to buy)
3.85
2024-04-02
4
A
0
1100000
A
2034-04-02
Common Stock
1100000
1100000
D
The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments.
Not applicable.
/s/ Manmeet Soni
2024-04-04